Figure 5From: Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort studyFollow-up of a patient positive for antibodies against human Heat Shock Protein 60 (anti-hHSP60). Anti-hHSP60 levels (■) drop as well as antibody levels against myeloperoxidase (MPO-ANCA) (◆) once treatment has commenced, but increase during follow-up, while MPO-ANCA levels remain undetectable.Back to article page